Biosimilar Approval: How FDA Reviews Biologic Alternatives in 2025
The FDA's 2025 update to biosimilar approval rules removes unnecessary clinical trials, making cheaper biologic alternatives faster and easier to bring to market. Learn how biosimilars are reviewed, why they're different from generics, and what this means for patients.